* AtriCure Inc ATRC.OQ reported a quarterly adjusted loss
of 27
cents per share for the quarter ended in September. The mean
expectation of seven analysts for the quarter was for a loss
of 25 cents per share.
* Revenue rose 18.1% to $83.25 million from a year ago;
analysts
expected $81.33 million.
* AtriCure Inc's reported EPS for the quarter was a loss
of 27
cents.
* The mean earnings estimate of analysts had risen by
about 1.1%
in the last three months.
* In the last 30 days one analyst negatively revised an
earnings
estimate
* AtriCure Inc shares had risen by 7.7% this quarter and
lost 39.4% so far this year.
* The company reported a quarterly loss of $12.27 million.
* Wall Street's median 12-month price target for AtriCure
Inc is
$65.00
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 6 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."
This summary was machine generated from Refinitiv data November
1 at 10:01 p.m. All figures in US dollars unless otherwise
stated. QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Sep. 30 2022 -0.25 -0.27 Missed
Jun. 30 2022 -0.29 -0.32 Missed
Mar. 31 2022 -0.32 -0.33 Missed
Dec. 31 2021 -0.29 -0.30 Missed